Respiratory Exacerbations in Children With Bronchopulmonary Dysplasia (BPD): A Case-Control Study
NCT07666438 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2026-06-24
Summary
This is an ambispective observational case-control study evaluating respiratory exacerbations in pediatric patients affected by bronchopulmonary dysplasia (BPD) compared with children without BPD. The study includes a retrospective cohort (January 2020 to September 2025) and a prospective cohort (from study approval to December 2030). Patients admitted to the Pediatric Emergency Department or Pediatric Unit for lower respiratory tract infections will be consecutively enrolled and managed according to standard clinical practice.
Conditions
- Severe Respiratory Exacerbation
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
lead OTHER
Eligibility
- Min Age
- 30 Days
- Max Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-17
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD
NCT04107701 ·Status: COMPLETED
-
Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia
NCT07725575 ·Status: COMPLETED ·Phase: PHASE4
-
Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD
NCT02723513 ·Status: COMPLETED ·Phase: NA
-
Neonatal Intensive Care (NICU) Course and Hospital Outcome of Infants With BPD Treated Using Inhaled Nitric Oxide
NCT00757146 ·Status: COMPLETED
-
Aerosolized Albuterol Use in Severe BPD
NCT02766673 ·Status: COMPLETED ·Phase: NA
-
Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies
NCT02443961 ·Status: COMPLETED ·Phase: PHASE1
-
Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children
NCT04391335 ·Status: RECRUITING
-
Little Lungs Study
NCT06855043 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
NCT01717625 ·Status: COMPLETED ·Phase: PHASE2
-
Hypophosphatemia and Bronchiolitis
NCT04814641 ·Status: UNKNOWN
-
Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia
NCT03503994 ·Status: COMPLETED ·Phase: NA
-
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
NCT03631420 ·Status: RECRUITING ·Phase: PHASE1
-
THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA
NCT06584474 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
NCT06897839 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Pulmonary Outcomes of Bronchopulmonary Dysplasia in Young Adulthood
NCT02820818 ·Status: COMPLETED
-
Stem Cells for Bronchopulmonary Dysplasia
NCT03378063 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia
NCT03601416 ·Status: UNKNOWN ·Phase: PHASE2
-
Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia
NCT03873506 ·Status: UNKNOWN ·Phase: PHASE1
-
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
NCT01503801 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia
NCT03558334 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia
NCT03035214 ·Status: UNKNOWN ·Phase: PHASE2
-
Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
NCT04019106 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates
NCT00623740 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia
NCT05534685 ·Status: UNKNOWN ·Phase: NA